No single ticker was named. Weight-loss & pharma ETFs are the exposure this bearish thesis argues against, most actionable for readers who already hold them. Not a recommendation.
GLP-1 drugs create secular risk for packaging
The guest argued that the rapid penetration of GLP-1 drugs (like Ozempic) creates a secular headwind for levered packaging companies tied to declining demand for wine bottles and beer cans.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.